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Abstract—The present study investigated the protective effects of Ginkgo biloba extract (EGb 761) on rat liver
mitochondrial damage induced by in vitro anoxia/reoxygenation. Anoxia/reoxygenation was known to impair respira-
tory activities and mitochondrial oxidative phosphorylation efficiency. ADP/O (2.57 6 0.11) decreased after anoxia/
reoxygenation (1.75 6 0.09, p , .01), as well as state 3 and uncoupled respiration (220%, p , .01), but state 4
respiration increased ( p , .01). EGb 761 (50–200 mg/ml) had no effect on mitochondrial functions before anoxia, but
had a specific dose-dependent protective effect after anoxia/reoxygenation. When mitochondria were incubated with 200
mg/ml EGb 761, they showed an increase in ADP/O (2.09 6 0.14, p , .05) and a decrease in state 4 respiration
(222%) after anoxia/reoxygenation. In EPR spin-trapping measurement, EGb 761 decreased the EPR signal of
superoxide anion produced during reoxygenation. In conclusion, EGb 761 specially protects mitochondrial ATP
synthesis against anoxia/reoxygenation injury by scavenging the superoxide anion generated by mitochondria. © 1999
Elsevier Science Inc.
Keywords—Ginkgo biloba extract, Mitochondria, Oxidative phosphorylation, Anoxia/reoxygenation, Superoxide an-
ion, EPR, Free radicals
INTRODUCTION
Ginkgo biloba extract (EGb 761) is known to act on
cardiac, cerebral, and pulmonary disorders, and results
were obtained with this extract for the treatment of
peripheral vascular disease and cerebrovascular insuffi-
ciency in the elderly population [1]. EGb 761 is a stan-
dardized product on the amount of 24% ginkgo-flavone
glycosides and 6% terpenoid. One of the mechanisms
proposed to underline the beneficial pharmacologic ef-
fects of EGb 761 was its antioxidant action [2–4]. Recent
studies have provided considerable support for the in
vitro and in vivo protective effects of EGb 761 in isch-
emia/reperfusion injury [5–8] or oxidative stress [9–11].
These effects were closely related to the ability of EGb
761 to scavenge free radicals such as superoxide anion
[12,13], hydroxyl and peroxyl radicals [3,14], and nitric
oxide [15]. Thus EGb 761 has wide antioxidant effects
and inhibits peroxidation reactions in vivo and in vitro
[16–19].
It is well known that organs submitted to ischemia/
reperfusion are widely damaged. Cytosolic sodium, cal-
cium, and inorganic phosphate contents rise [20] and
ATP content decreases. These cellular modifications may
induce mitochondrial dysfunctions such as uncoupled
respiration, permeability transition [21,22], and swelling
[23]. Moreover, mitochondria may produce oxygen rad-
icals at the level of respiratory chain [24–26]. Because
mitochondria have been recognized to generate free rad-
icals and mitochondrial functions were impaired after in
vivo ischemia/reperfusion [27–30], mitochondria have
been implicated in the ischemia/reperfusion injury.
Moreover, our previous studies showed that several re-
spiratory parameters were impaired in isolated liver mi-
tochondria after in vitro anoxia/reoxygenation [31].
These lesions were directly related to superoxide anion
production during reoxygenation and were proposed to
be secondary to this production. These results [31] sup-
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ported that in our incubation conditions (Ca21-free me-
dium), mitochondrial enzymes were the first targets of
mitochondrial-free radical production, and there was no
damage in the inner membrane proton conductivity after
reoxygenation (no proton leak). This is consistent with
the oxidative damage of proteins induced by oxygen
radicals [32].
The purpose of the present study was to investigate
the in vitro effects of EGb 761 on isolated liver mito-
chondria in order to define the EGb 761 protective ef-
fects on specific functional damage induced by anoxia/
reoxygenation.
MATERIALS AND METHODS
Isolation of rat liver mitochondria
Male Wistar rats (200–250 g) were used in this study
and received care in accordance with the Guide for the
Care and Use of Laboratory Animals (National Institutes
of Health Publication 85-23, revised 1985). The protocol
for the study was approved by the Animal Care Com-
mittee at the University of Lie`ge, Belgium.
Rats were decapitated, and their livers were harvested
and rinsed with an ice-cold MSET buffer (210 mM
mannitol, 70 mM sucrose, 0.5 mM ethylenediamine tetra-
acetate [EDTA], and 10 mM Tris) at pH 7.4. Livers were
trimmed and homogenized 1 min with a motor-driven
handheld homogenizer in the presence of MSET solution
(5 g/35 ml) at 4°C. Mitochondria were isolated from the
solution with a standard technique of differential centrif-
ugations with a Beckman J2-HC Centrifuge (Palo Alto,
CA, USA). Liver homogenate was centrifuged at
1000 3 g for 10 min and its supernatant at 12,000 3 g
for 10 min. The pellet was resuspended with MSET
solution and resedimented at 12,000 3 g for 10 min
twice before obtaining final mitochondrial suspension.
The surface of the last pellet was rinsed with 5 ml MSET
solution and suspended in a sucrose-Tris buffer (280 mM
sucrose, 0.5 mM EDTA, and 10 mM Tris) at 4°C. The
mitochondrial proteins were estimated spectrophoto-
metrically by the method of Peterson [33].
Measurement of mitochondrial respiratory parameters
Respiratory parameters of isolated liver mitochondria
were determined at 25°C with a respirometer (Physica
respirometer, Paar Physica, Innsbruck, Austria) by in
vitro measurement of oxygen consumption rates in 2 ml
of air saturated calcium-free reaction medium at pH 7.4
(15 mM KCl, 1 mM EDTA, 5 mM MgCl2, 50 mM Tris),
in the presence of 2.5 mM phosphate (KH2PO4). Oxi-
dizable substrates were 5 mM ketoglutarate and 5 mM
pyruvate (reduced nicotinamide adenine dinucleotide
phosphate [NADH]-linked substrates). The concentra-
tion of added adenosine diphosphate (ADP), oligomycin,
and uncoupler carbonylcyanide-p-trifluoro-methoxyphe-
nylhydrazone (FCCP) was 165 mM (ADP pulse), 2.5
mM (saturating ADP), 16 mg/ml, and 5 mM, respec-
tively. The amount of mitochondrial proteins for respi-
ratory measurement was approximately 0.5 mg protein/
ml.
The measured functional parameters of mitochondria
were (i) the respiration rates in the presence of externally
added ADP (V3 during ADP pulse and V3s with saturat-
ing ADP) or in its absence (V4), which were used to
calculate the respiratory control (RC) given by the ratio
V3/V4; (ii) the respiration rates when ATP synthase is
blocked by oligomycin (VOlig) or in the presence of the
uncoupler FCCP (VFCCP) which were used to calculate
the uncoupled respiratory control (URC) given by the
ratio VFCCP/VOlig; (iii) the yield of the oxidative phos-
phorylation, i.e., the number of moles of ADP phosphor-
ylated by atom gram of oxygen consumed (ADP/O).
Anoxia and reoxygenation
Anoxia was performed by mitochondria consuming
the oxygen in reaction medium after several ADP pulses
into a closed incubation chamber. The anaerobic condi-
tions were reached in state 4 respiration and anoxia
duration was 1, 5, or 10 min. Anoxia was followed by
4 6 1 min of in vitro reoxygenation (until 90% of
oxygen saturation) by exposing the stirred reaction me-
dium to air. Then, the oxymeter chamber was closed and
respiratory parameters were again measured.
In vitro aging of mitochondria during respiratory as-
says was followed in a “time control.” Mitochondria
were incubated during 20 min in the stirred reaction
medium exposed to air. They received ADP pulses in an
open incubation chamber. After 20 min, the oxymeter
chamber was closed and respiratory parameters were
measured as described above.
Measurement of the respiratory parameters was also
performed in the presence of 50, 100, and 200 mg/ml of
EGb 761 (IPSEN, Paris, France). Mitochondria were
incubated with EGb 761 from the beginning of the re-
spiratory assay, before anoxia/reoxygenation. The anox-
ia/reoxygenation procedure was described previously.
EPR measurements
Superoxide anion production by the mitochondrial
suspension (10 mg protein/ml) was measured by electron
paramagnetic resonance (EPR) spin trapping with 50
mM POBN in the presence of 2% ethanol [34]. POBN
was able to cross the mitochondrial membrane and in-
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teract with superoxide anion produced on the matrix side
of the membrane. Mitochondria were incubated with
POBN from the beginning of measurement in order to
allow appropriate partitioning of POBN. Samples were
taken for EPR measurement at the end of the anoxia
period and after reoxygenation, during the postanoxic
respiration. In EPR experiments, isolated liver mitochon-
dria were incubated with POBN and EGb 761 (50, 100,
and 200 mg/ml) from the beginning of assay.
In order to investigate the direct effects of EGb 761
(200 mg/ml) on the superoxide anion produced in vitro,
the reaction of xanthine with xanthine oxidase was used
as source of superoxide anion [35] in the presence of
either POBN/EtOH or DMPO as spin trap agents. The
reaction mixture contained 1 mM xanthine, 100 mM spin
trap (POBN or DMPO), and 0.08 unit/ml of xanthine
oxidase.
Measurements were performed with EPR 300E Spec-
tometer (Bruker, Karlsruhe, Germany) at operating X-
band (9.56 GHz). Instrumental settings were modulation
frequency 100 kHz, amplitude modulation 1.01 Gauss,
receiver gain 2 3 104, time conversion 81.92 ms, time
constant 163.84 ms, resulting sweep time 83.89 s, num-
ber of scans 10, microwave frequency 9.56 GHz, micro-
wave power 20 mW, width sweep 100 Gauss, and center
field 3480 Gauss.
Chemicals
Ginkgo biloba extract (EGb 761) was provided by
IPSEN. Adenosine-59-diphosphate (ADP), ketoglutarate,
pyruvate, and xanthine oxidase were purchased from
Boehringher-Mannheim Biochemica (Mannheim, Ger-
many); carbonylcyanide-p-trifluoro-methoxyphenylhy-
drazone (FCCP) was from Du Pont de Nemours (Wil-
mington, DE, USA); oligomycin, a-(4-pyridyl-1-oxide)-
N-tert-butylnitrone (POBN), and 5,5-dimethyl-1-
pyrroline-N-oxide (DMPO) were from Sigma Chemical
Co. (St. Louis, MO, USA). DMPO was purified with
activated charcoal [36]. In the absence of specific indi-
cations, the other chemicals used in this study were
purchased from Merck (Darmstadt, Germany).
Calculation and statistics
Respiratory parameter data were analyzed with Dat-
Graf Software (Oroboros, Innsbruck, Austria). Oxygen
concentration in the medium was calculated from pO2
measurements based on O2 solubility in the respiration
medium at 25°C.
All data were presented as means 6 SD. One-way
analysis of variance (ANOVA) design and correspond-
ing Student’s t-test were used to analyze the mitochon-
drial oxygen consumption data. Results of the tests were
expressed by their p value, and p , .05 was taken to be
statistically significant.
RESULTS
Effects of anoxia/reoxygenation on liver mitochondria
The respiratory parameters of isolated liver mitochon-
dria were measured before anoxia (control) and after 1
min anoxia followed by 4 6 1 min reoxygenation. At
first glance, damage induced by anoxia/reoxygenation
were important at the level of ADP pulses (e.g., Fig. 1A).
There was a broadening of the peak in the slope curve
(first derivative). Anoxia/reoxygenation induced a signif-
icant decrease in state 3 respiration rate (V3, 98.6 6 5.1
to 77.5 6 3.8, p , .01), uncoupled respiration rate
(VFCCP) [31], and ADP/O ratio [from 2.57 6 0.11 ( p ,
.01) to 1.75 6 0.09 ( p , .001)]. Moreover, state 4
respiration rate (V4) increased (25.5 6 1.7 to 36.8 6
4.5, p , .01) with no change in oligomycin respiration
rate (VOlig) [31]. The results indicated a decrease in the
mitochondrial respiratory chain activities and a drop of
the oxidative phosphorylation efficiency. However, the
mitochondrial membrane permeability was not altered
(stable VOlig). These effects were independent of anoxia
duration (5 and 10 min anoxia; data not shown).
In order to verify whether these damage were due to
anoxia/reoxygenation or to in vitro aging of mitochon-
dria during respiratory assay, we measured the respira-
tory parameters after 20 min incubation in a stirred
reaction medium exposed to air (time control). To mimic
preanoxic respiration, we realized 4 ADP pulses during
the time control. Compared with control, mitochondrial
respiratory parameters after 20 min in vitro incubation
were not different from those of preanoxic respirations
(Fig. 1). ADP/O was not significantly modified (from
2.44 6 0.12 to 2.34 6 0.11). Therefore, we can conclude
that there is no in vitro time-dependent decline of liver
mitochondrial function during the respiratory assay.
Thus, mitochondrial damage after anoxia/reoxygenation
were not due to in vitro aging.
Protective effects of EGb 761 during
anoxia/reoxygenation
Relative to control, EGb 761 administration (50, 100,
and 200 mg/ml) induced no significant modification in
the respiratory parameters before anoxia/reoxygenation
(Figs. 2–4). Thus, EGb 761 addition in the incubation
medium did not impair the mitochondrial respiratory
functions.
After anoxia/reoxygenation, V3, V3s, VFCCP, and
VOlig were not significantly modified in the presence of
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EGb 761 (Figs. 2 and 3), relative to anoxia/reoxygen-
ation without EGb 761. However, V4 decreased with
increasing of EGb 761 concentration (Figs. 2 and 4A)
and was significantly lower at 200 mg/ml EGb 761
(36.8 6 4.5 to 24.6 6 3.2, p , .01). Moreover, in the
presence of EGb 761, the oxidative phosphorylation ef-
ficiency (ADP/O ratio) was higher (1.75 6 0.09 to
2.09 6 0.14, p , .01) than in its absence (Figs. 2 and
4B). EGb 761 significantly protected ( p , .01) the
ADP/O ratio at 50 and 100 mg/ml (22%), but the pro-
tection was 48% at 200 mg/ml ( p , .001). Thus, EGb
761 protected the mitochondrial oxidative phosphoryla-
tion efficiency against damage induced by in vitro anox-
ia/reoxygenation but did not improve the phosphorylat-
ing and uncoupled respirations.
Effects of EGb 761 on EPR signal
Controls were EPR spectra of the POBN/ethanol me-
dium without mitochondria (Fig. 5A). After ADP pulses,
mitochondria reached anoxia in state 4 and 10 min an-
oxia occurred. At the end of the anoxia period, a first
sample was harvested for EPR measurement. The EPR
spectra showed that a small amount of superoxide anion
was produced during preanoxic respiration (Fig. 5B). In
a second sample, a significant increase of EPR signal
intensity was observed after reoxygenation (Fig. 5C).
This indicated an increase of superoxide anion produc-
tion during postanoxic reoxygenation, as previously ob-
served [31]. Mitochondria incubated with 50 mM POBN,
2% ethanol, and 200 mg/ml EGb 761 showed a de-
crease in the EPR signal intensity after anoxia/reoxy-
genation (Fig. 5D). EGb 761 could decrease the EPR
signal intensity because its antioxidant properties al-
low to scavenge the superoxide anion produced during
reoxygenation.
Effects of EGb 761 on the EPR signals of superoxide
anion generated in vitro
Superoxide anion was produced in vitro by the xan-
thine/xanthine oxidase system in order to verify the di-
rect scavenging effect of EGb 761. Controls were EPR
spectra of POBN/ethanol and DMPO without xanthine
oxidase (Figs. 6A and 7A). The EPR spectra in Figs. 6B
and 7B represented POBN/ethanol and DMPO adducts,
respectively, resulting of the reaction of these spin traps
with superoxide anion. Addition of EGb 761 (200 mg/ml)
in the reaction mixture showed a decrease of the EPR
signal intensity of POBN/ethanol adduct (Fig. 6C). Sim-
ilarly, the same concentration of EGb 761 caused a
decrease of the EPR signal intensity of DMPO/OOH
adduct (Fig. 7C). These results demonstrated that EGb
761 actually scavenged superoxide anion as indicated in
experiments with mitochondria after reoxygenation.
DISCUSSION
It is well known that ischemia/reperfusion leads to
cellular damage, with among others, a decrease in the
mitochondrial function [8,30,37]. Other studies have
shown that mitochondria were implicated in liver and
cerebral ischemia/reperfusion injury [27,28]. Moreover,
mitochondria have been recognized to generate free rad-
icals [25,26]. Thus in our previous experiments, we have
Fig. 1. Effects of anoxia/reoxygenation and in vitro aging on the
respiratory functions of rat liver mitochondria. Oxygen-concentration
traces (mM) and its first derivative (nmol/min/mg protein) are shown.
Mitochondria were incubated at 25°C in 2 ml of medium containing 15
mM KCl, 1 mM EDTA, 5 mM MgCl2, 50 mM Tris, and 2.5 mM
phosphate with 5 mM ketoglutarate and pyruvate as oxidizable sub-
strates. Anoxia (1 min) was reached in state 4 after ADP pulses and
reoxygenation was 4 6 1 min by exposing the stirred reaction medium
to air. ADP was added at 165 mM (pulses) or 2.5 mM (saturating ADP).
Oligomycin and FCCP concentrations were 16 mg/ml and 5 mM,
respectively. (A) Anoxia/reoxygenation. (B) Time control, when mito-
chondria were incubated 20 min in the stirred incubation medium
exposed to air.
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reported [31] that in vitro anoxia/reoxygenation induced
mitochondrial dysfunction in liver mitochondria and
generated superoxide anion.
In this study, we investigated the oxidative phosphor-
ylation function in isolated liver mitochondria submitted
to in vitro anoxia/reoxygenation in the presence of EGb
761. The measurements of mitochondrial respiratory pa-
rameters allow us to point out dysfunctions induced by
anoxia/reoxygenation. Analysis of the respiratory param-
eters allows us to describe and to identify the location of
the mitochondrial damage, i.e., phospholipid bilayer per-
meability, enzyme activity, and substrate or ADP avail-
ability. Indeed, according to the chemiosmotic coupling
between respiration and ATP synthesis [38], 10–12 pro-
tons are extruded from the mitochondria for each oxygen
atom consumed [39] and 4 protons are taken up to
synthesize one ATP. Such proton stoichiometry rules
implicate the existence of stoichiometric ratios H1/O,
H1/ATP, and ADP/O. These ratios are fully respected in
tightly coupled mitochondria because their inner mem-
brane is impermeable to protons (no proton leak).
According to the observed modifications of the func-
tional parameters, mitochondrial damage can be located
at several levels. Oligomycin resistant respiration rate
(VOlig), sustained by proton leak, informs on membrane
damage increasing proton permeability. Increase in VOlig
indicates an increase in proton leak through the inner
mitochondrial membrane which alters the chemiosmotic
coupling. If V4 (nonphosphorylating respiration after
complete consumption of externally added ADP) in-
Fig. 2. Effects of EGb 761 on the respiratory functions of rat liver mitochondria after anoxia/reoxygenation. Oxygen-concentration
traces (mM) and its first derivative (nmol/min/mg protein) are shown. Mitochondria were incubated at 25°C in 2 ml of medium
described in Fig. 1 with 5 mM ketoglutarate and pyruvate as oxidizable substrates. Anoxia (1 min) was reached in state 4 after ADP
pulses and reoxygenation was 4 6 1 min. ADP, oligomycin, and FCCP concentrations as in Fig. 1. EGb 761 (50, 100, and 200 mg/ml)
was in the incubation medium from the beginning of the respiratory assay. Anoxia/reoxygenation was performed without EGb 761 (A)
or in the presence of 50 mg/ml (B), 100 mg/ml (C), and 200 mg/ml (D) of EGb 761.
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creases and VOlig does not increase, the membrane lipid
bilayer is not damaged but the intrinsic stoichiometry of
ATP synthase is impaired (proton slip, i.e., intrinsic
uncoupling of ATP synthase). When phosphorylating
(V3, V3s) and uncoupled (VFCCP) respiration rates de-
crease, either the respiratory chain oxido-reductases are
intrinsically damaged, or the upstream feeding of the
respiratory chain with electrons is limiting (oxidizable
substrate availability). Proton leak (membrane damage)
and/or proton slip (modification of intrinsic proton stoi-
chiometry of redox pump and/or ATP synthase) lead to a
decrease in ADP/O ratio, i.e., a decrease in the oxidative
phosphorylation efficiency.
In accordance with previous results [31], anoxia/
reoxygenation of liver mitochondria induced a decrease
in phosphorylating and uncoupled respiration rates and a
decrease in the ADP/O ratio. The decrease in rates dem-
onstrated that 1 min anoxia followed by 5 min reoxy-
genation altered either the oxido-reductases of the respi-
ratory chain or the oxidizable substrate availability. As
the same substrate concentrations were provided in all
measurements, a decrease in substrate availability could
only be due to partial inactivation of ketoglutarate and/or
pyruvate translocators or of their deshydrogenases. The
decrease in the ADP/O ratio, indicating an alteration of
the oxidative phosphorylation efficiency, was linked to a
proton slip at the level of ATP synthase. Indeed, anoxia/
reoxygenation did not induce proton leak (stable VOlig)
and the resting respiration (V4) increased. The absence of
proton leak indicated that there was no alteration of the
Fig. 3. Effects of EGb 761 on phosphorylating and uncoupled respira-
tion rates before and after anoxia/reoxygenation (A/R). Respiration
rates were expressed in nanomoles of oxygen consumed per minute and
per milligram of mitochondrial protein. Data were means 6 SD (n 5
4). Respiratory parameters were measured in the absence (0) or in the
presence of EGb 761 (50, 100, and 200 mg/ml). (A) Phosphorylating
respiration (V3) was measured before and after A/R. (B) Respiration
rate with saturating ADP (V3s) and in the presence of uncoupler FCCP
(VFCCP) was measured after A/R.
Fig. 4. Effects of EGb 761 on resting respiration rate and ADP/O ratio
before and after anoxia/reoxygenation (A/R). Resting respiration rate
(V4) was expressed in nanomoles of oxygen consumed per minute and
per milligram of mitochondrial protein. Data were means 6 SD (n 5
4). Statistical significance was p , .01 (**) vs. data before anoxia, and
p , .01 (11) or p , .05 (1) vs. data after A/R (no EGb 761).
Mitochondrial parameters were measured in the absence (0) or in the
presence of EGb 761 (50, 100, and 200 mg/ml). (A) Resting respiration
rate (V4) was measured before and after A/R. (B) ADP/O ratio, i.e., the
number of moles of ADP phosphorylated by atom gram of oxygen
consumed, was calculated before and after A/R.
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membrane permeability. The ADP/O decrease and V4
increase were in accordance to prove that anoxia/reoxy-
genation induced a proton slip at the level of the ATP
synthase, as mentioned above. These latter functional
impairments supported that ATP synthase was damaged
by anoxia/reoxygenation.
These results on isolated liver mitochondria showed
that in vitro anoxia/reoxygenation induced mitochondrial
dysfunction. In the same field, Caraceni et al. [40] related
that superoxide anion generated by the respiratory chain
during reoxygenation of hepatocytes could be partly re-
sponsible for mitochondrial damage. Thus, anoxia/
reoxygenation induced mitochondrial dysfunction and
reactive oxygen species were produced during reoxygen-
ation [27,29]. Because mitochondria were damaged by
anoxia/reoxygenation, it was of great interest to study the
effect of antioxidants on the mitochondrial function. In
the present study, we decided to use EGb 761, the
Ginkgo biloba extract. EGb 761 was well known for its
antioxidant properties [3,12,14,15] and its protective ef-
fects against injuries induced by in vivo ischemia/reper-
fusion [2,7,8] EGb 761 was used at 50, 100, and 200
mg/ml, concentrations that did not impair the mitochon-
drial respiratory parameters before anoxia/reoxygenation
(Figs. 3A and 4).
Respiratory parameters were measured after anoxia/
reoxygenation in the presence of EGb 761. Mitochondria
were incubated with EGb 761 from the beginning of the
respiratory assay, before anoxia/reoxygenation. Relative
to anoxia/reoxygenation without EGb 761, V3, V3s,
VFCCP, and VOlig were not modified (Figs. 2 and 3). As
EGb 761 did not change the phosphorylating and uncou-
pled respiration rates, there was no protective effect on
Fig. 5. Effects of EGb 761 on EPR spectra obtained with POBN/
ethanol as spin trap. Mitochondria (10 mg protein/ml) were incubated
in a medium containing 15 mM KCl, 1 mM EDTA, 5 mM MgCl2, 50
mM Tris, and 2.5 mM phosphate with 5 mM ketoglutarate and pyru-
vate. Spectrum (A) (control) was obtained with 50 mM POBN and 2%
ethanol without mitochondria, spectrum (B) with a sample harvested at
the end of 10 min anoxia, and spectrum (C) after anoxia and 5 min
reoxygenation. In spectrum (D), a sample of mitochondria incubated
with 200 mg/ml EGb 761 was harvested after reoxygenation.
Fig. 6. Effects of EGb 761 on the EPR spectra of superoxide anion
produced in vitro in the presence of POBN/ethanol as spin trap,
xanthine (1 mM), xanthine oxidase (0.08 unit/ml), and 50 mM phos-
phate buffer (pH 7.8). Spectrum (A) (control) was obtained with 100
mM POBN and 2% ethanol without xanthine oxidase; spectra (B) and
(C) were obtained with xanthine oxidase without and with 200 mg/ml
EGb 761, respectively. Instrumental settings were as described in Materi-
als and Methods except receiver gain 1.105 and number of scans 6.
Fig. 7. Effects of EGb 761 on the EPR spectra of superoxide anion
produced in vitro in the presence of DMPO as spin trap. Superoxide
anion generation system was the same as in Fig. 6. Spectrum (A)
(control) was obtained with 100 mM DMPO without xanthine oxidase;
spectra (B) and (C) were obtained with xanthine oxidase without and
with 200 mg/ml EGb 761, respectively. Instrumental settings were as
described in Materials and Methods except receiver gain 1.105 and
number of scans 6.
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the oxido-reductase activities of the respiratory chain.
However, EGb 761, even at the lower concentration,
protected the oxidative phosphorylation efficiency (Fig.
4) as shown by the ADP/O ratio. This protection was
22% at 50 and 100 mg/ml, and 48% at 200 mg/ml.
Thus in the presence of EGb 761, the proton slip of the
ATP synthase was reduced (V4 decreased and ADP/O
increased).
EGb 761 protected the mitochondrial oxidative phos-
phorylation efficiency against damage induced by in
vitro anoxia/reoxygenation, probably by its antioxidant
action. EGb 761 was able to react with superoxide anion
[12] and to scavenge free radicals. In our EPR experi-
ments, we have shown that anoxia/reoxygenation in the
presence of EGb 761 (200 mg/ml) decreased the EPR
signal intensity (Fig. 5). This implicated that EGb 761
scavenged free radicals, essentially superoxide anion, as
demonstrated when superoxide anion was generated by
an in vitro system with xanthine/xanthine oxidase (Figs.
6 and 7). The protection of mitochondrial function by
EGb 761 is thus related to its antioxidant properties.
However, it should be noted that EGb 761 and the spin
trap POBN could compete to scavenge superoxide anion.
In this case, the decrease of EPR signal intensity in the
presence of EGb 761 underestimated the scavenging
effect of EGb 761.
In conclusion, EGb 761 protects mitochondria against
damage induced by anoxia/reoxygenation. In fact, super-
oxide anion produced by the respiratory chain during
reoxygenation impairs the ATP synthase activity (proton
slip) and EGb 761 protects this enzyme by superoxide
anion scavenging. Another study is in progress in our
laboratory to understand the selective protection of ATP
synthase by EGb 761.
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ABBREVIATIONS
ADP/O—number of moles of ADP phosphorylated by
atom gram of oxygen consumed
A/R—anoxia/reoxygenation
DMPO—5,5-dimethyl-1-pyrroline-N-oxide








VOlig—respiration rate in the presence of oligomycin
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